Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
9.78
+0.47 (5.05%)
At close: Jun 26, 2026, 4:00 PM EDT
9.59
-0.19 (-1.94%)
After-hours: Jun 26, 2026, 7:26 PM EDT
Orthofix Medical Employees
Orthofix Medical had 1,605 employees as of December 31, 2025. The number of employees decreased by 11 or -0.68% compared to the previous year.
Employees
1,605
Change (1Y)
-11
Growth (1Y)
-0.68%
Revenue / Employee
$514,252
Profits / Employee
-$37,387
Market Cap
395.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,605 | -11 | -0.68% |
| Dec 31, 2024 | 1,616 | -18 | -1.10% |
| Dec 31, 2023 | 1,634 | 542 | 49.63% |
| Dec 31, 2022 | 1,092 | 5 | 0.46% |
| Dec 31, 2021 | 1,087 | 51 | 4.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,450 |
| Viemed Healthcare | 1,387 |
| Pacific Biosciences of California | 485 |
| Standard BioTools | 389 |
| Electromed | 180 |
| 908 Devices | 172 |
| Perspective Therapeutics | 166 |
| Delcath Systems | 156 |
OFIX News
- 18 days ago - Orthofix Medical Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 5 weeks ago - Orthofix price target lowered to $15 from $17 at Barrington - TheFly
- 5 weeks ago - Orthofix price target lowered to $15 from $18 at Stifel - TheFly
- 5 weeks ago - Orthofix price target lowered to $18 from $20 at Canaccord - TheFly
- 5 weeks ago - Orthofix price target lowered to $12 from $14 at TD Cowen - TheFly
- 5 weeks ago - Orthofix cuts FY26 revenue view to $838M-$848M from $850M-$860M - TheFly
- 5 weeks ago - Orthofix cuts FY revenue guidance, shares down 19.6% to $9.77 - TheFly